C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 84 filers reported holding C4 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $169,245 | -32.5% | 90,992 | -0.2% | 0.00% | – |
| Q2 2023 | $250,685 | -79.2% | 91,158 | -76.3% | 0.00% | – |
| Q1 2023 | $1,207,656 | -48.7% | 384,604 | -3.6% | 0.00% | – |
| Q4 2022 | $2,354,288 | -29.7% | 399,032 | +4.5% | 0.00% | -100.0% |
| Q3 2022 | $3,350,000 | +19.9% | 381,983 | +3.1% | 0.00% | 0.0% |
| Q2 2022 | $2,793,000 | -67.0% | 370,520 | +6.1% | 0.00% | 0.0% |
| Q1 2022 | $8,474,000 | -27.2% | 349,262 | -3.4% | 0.00% | -50.0% |
| Q4 2021 | $11,648,000 | -28.4% | 361,696 | -0.6% | 0.00% | -33.3% |
| Q3 2021 | $16,261,000 | +41.7% | 363,953 | +20.0% | 0.00% | +50.0% |
| Q2 2021 | $11,479,000 | +160.6% | 303,379 | +154.8% | 0.00% | +100.0% |
| Q1 2021 | $4,405,000 | +6.3% | 119,076 | -4.8% | 0.00% | 0.0% |
| Q4 2020 | $4,144,000 | – | 125,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |